Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Dennis J. Slamon | Researchclopedia

Back to researchers

Dennis J. Slamon

APLA Health ORCID

984

Works

100,093

Citations

126

h-index

345

i10-index

Research Topics

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Advanced Breast Cancer Therapies

Affiliations

University College Dublin2010–2010

Université Paris-Sud2016–2017

AstraZeneca (United Kingdom)2010–2010

Hiroshima University1985–1991

University of Southern California1988–2017

Top Works

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon,Gary M. Clark,et al.

198711,686 citations

Cancer Treatment and Pharmacology

Lung Cancer Research Studies

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon,Brian Leyland‐Jones,et al.

200111,443 citations

Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer

Dennis J. Slamon,William Godolphin,et al.

19896,839 citations

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn,Miguel Martín,et al.

20162,882 citations

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Melody Cobleigh,Charles L. Vogel,et al.

19992,788 citations

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis J. Slamon,W. Eiermann,et al.

20112,752 citations

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Katherine B. Chiappinelli,Pamela L. Strissel,et al.

20151,945 citations

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

Richard S. Finn,John Crown,et al.

20141,892 citations

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of <i>HER2</i>-Overexpressing Metastatic Breast Cancer

Charles L. Vogel,Melody Cobleigh,et al.

20021,854 citations